← 產業報告目錄
Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Size, Share & Trends Analysis Report by Application (Cancer Diagnostics, Non-Invasive Prenatal Testing (NIPT), Transplant Monitoring, Infectious Disease Detection, Other (e.g., Metabolic Disorders)), By Technology, By End-User, By Product, By Region, And by Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-11頁數 180報告編號 INSIGHTACE-0a5a4b4ec0
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide Circulating Cell-Free DNA (ccfDNA) Diagnostics Market is forecasted to register a CAGR of 8.8%.
The Circulating Cell-Free DNA (ccfDNA) Diagnostics sector involves dynamics.
Growth is underpinned by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Snapshot
Chapter 4. Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on CIRCULATING CELL-FREE DNA (CCFDNA) DIAGNOSTICS MARKET Industry Trends
Chapter 5. Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Segmentation 1: By Technology, Estimates & Trend Analysis
5.1. Market Share by Technology, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
5.2.1. Next-Generation Sequencing (NGS)
5.2.2. Digital PCR (dPCR)
5.2.3. Quantitative Real-Time PCR (qPCR)
5.2.4. Others (e.g., Mass Spectrometry)
Chapter 6. Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Cancer Diagnostics
6.2.2. Non-Invasive Prenatal Testing (NIPT)
6.2.3. Transplant Monitoring
6.2.4. Infectious Disease Detection
6.2.5. Other (e.g., Metabolic Disorders)
Chapter 7. Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Segmentation 3: By Product, Estimates & Trend Analysis
7.1. Market Share by Product, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:
7.2.1. Assays/Tests
7.2.2. Kits
7.2.3. Instruments
7.2.4. Software/Analytics
7.2.5. Services
Chapter 8. Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
8.2.1. Hospitals & Clinics
8.2.2. Diagnostic Laboratories
8.2.3. Research Institutions
8.2.4. Consumers (Home Testing)
Chapter 9. Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.2.3. North America Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. North America Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.2.5. North America Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3. Europe
9.3.1. Europe Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.3.3. Europe Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Europe Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.3.5. Europe Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. South Korea
9.4.1.5. Southeast Asia
9.4.1.6. Rest of Asia Pacific
9.4.2. Asia Pacific Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.4.3. Asia Pacific Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Asia Pacific Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts By Product, 2021-2034
9.4.5. Asia Pacific Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5. Latin America
9.5.1. Latin America Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Argentina
9.5.1.4. Rest of Latin America
9.5.2. Latin America Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.5.3. Latin America Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Latin America Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.5.5. Latin America Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. South Africa
9.6.1.3. Rest of Middle East and Africa
9.6.2. Middle East & Africa Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.6.3. Middle East & Africa Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.4. Middle East & Africa Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.6.5. Middle East & Africa Circulating Cell-Free DNA (ccfDNA) Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Hoffmann-La Roche
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Natera Inc.
10.2.3. Illumina Inc.
10.2.4. Agena Bioscience
10.2.5. Paragon Genomics
10.2.6. Thermo Fisher Scientific
10.2.7. Bio-Rad Laboratories
10.2.8. Lucence Health
10.2.9. Eurofins
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們